-
DAVYCA-F
[pdf-embedder url="https://davipharm.info/wp-content/uploads/DAVYCA_F.pdf"] -
DAVYCA
[pdf-embedder url="https://davipharm.info/wp-content/uploads/DAVYCA_07.pdf"] -
VALMAGOL
Magnesi valproat is indicated for: - Epilepsy - Treatment of manic episodes associated with bipolar disorder This is only the preview. Please check here for… -
ZAPNEX-10
Treatment of schizophrenia. Maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response. Treatment of moderate to severe manic… -
WAZER
Major depressive episodes. Panic disorder. Obsessive-compulsive disorder. This is only the preview. Please check here for the full indication. -
SULLIVAN
Amisulprid is indicated for the treatment of acute and chronic schizophrenic disorders in which positive symptoms (such as delusions, hallucinations and thought disorders) and/or negative… -
STOGURAD
Short term symptomatic treatment of anxiety in adults with failure standard treatments. Severe behavioral disorder in children (agitation, self-amputation, stereotypy), especially in the context of… -
SHAKES
Treatment of episodes of major depression. This is only the preview. Please check here for the full indication. -
SERNAL-4
The acute and maintenance treatment of schizophrenia (both negative and positive symptoms). When deciding to use long-term risperidon, it should periodically re-evaluate the effectiveness of… -
QUEITOZ-100
Quetiapine is indicated for: • Treatment of schizophrenia. • Treatment of bipolar disorder: - For the treatment of moderate to severe manic episodes in bipolar… -
CERAHEAD-F
Symptomatic treatment of vertigo. Elderly suffering from loss of memory, vertigo, lack of concentration or alertness, changes of mood, deterioration in behaviour, personal negligence, dementia… -
ZAPNEX-5
Treatment of schizophrenia. Maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response. Treatment of moderate to severe manic… -
SERNAL
The acute and maintenance treatment of schizophrenia (both negative and positive symptoms). When deciding to use long-term risperidon, it should periodically re-evaluate the effectiveness of… -
NILKEY
Acute and maintenance treatment of Major Depressive Disorder. Acute and maintenance treatment of obsessions and compulsions in patients with Obsessive Compulsive Disorder (OCD). Acute and… -
MANZURA-7.5
Treatment of schizophrenia. Maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response. Treatment of moderate to severe manic… -
MANZURA-5
Treatment of schizophrenia. Maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response. Treatment of moderate to severe manic… -
MANZURA-15
Treatment of schizophrenia. Maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response. Treatment of moderate to severe manic… -
LEVETRAL-750
Monotherapy in the treatment of partial onset seizures with or without secondary generalisation in adults and adolescents from 16 years of age with newly diagnosed… -
LEVETRAL
Monotherapy in the treatment of partial onset seizures with or without secondary generalisation in adults and adolescents from 16 years of age with newly diagnosed… -
KEIKAI
Monotherapy for the short-term treatment of primary insomnia characterised by poor quality of sleep in patients who are aged 55 or over. This is only… -
KAUSKAS-50
Epilepsy Adults and adolescents aged 13 years and above - Adjunctive or monotherapy treatment of partial seizures and generalised seizures, including tonic-clonic seizures. - Seizures… -
KAUSKAS-200
Epilepsy Adults and adolescents aged 13 years and above - Adjunctive or monotherapy treatment of partial seizures and generalised seizures, including tonic-clonic seizures. - Seizures…